Proteome Sciences PLC
20 April 2000
Proteome Sciences ('the Company' or 'Proteome')
Proteome announces the result of the vote on the resolutions proposed at
today's Extraordinary General Meeting, held in connection with the Placing and
the Open Offer described in the Company's prospectus dated 28 March 2000.
The special resolution 1 was duly passed and, accordingly, the authorised
share capital of the Company has been increased from £3,000,000 to £3,200,000.
Furthermore the directors have been generally and unconditionally authorised
to allot Ordinary Shares in connection with the Placing and the Open Offer
having an aggregate nominal amount of £139,774.11 and to make such allotments
on a non pre-emptive basis.
The ordinary resolution 2 was duly passed and, accordingly, the directors have
been generally and unconditionally authorised to allot Ordinary Shares up to
an aggregate nominal amount of £318,602.56 until the expiry of five years from
the passing of the resolution.
The special resolution 3 was duly passed and, accordingly, the directors have
been authorised to allot securities of the Company for cash on a non
premeptive basis up to an aggregate nominal amount of £47,790.38 and as
detailed in the notice convening the EGM.
The ordinary resolution 4 was duly passed and, accordingly, the directors have
been authorised to grant options to R. Stephen Harris, Professor William
Dawson and Professor Keith Mansford.
The Placing and Open Offer remain conditional upon admission of the new
Ordinary Shares to trading on AIM.
The new Ordinary Shares to be allotted pursuant to the Placing and the Open
Offer are expected to commence trading on AIM at 8.30 a.m. on 25 April 2000.